Novel Antimicrobial Agents Targeting Drug Resistant Bacterial Biofilms

Award Information
Agency:
Department of Defense
Amount:
$738,292.00
Program:
STTR
Contract:
W911NF-12-C-0007
Solitcitation Year:
2009
Solicitation Number:
2009.A
Branch:
Army
Award Year:
2012
Phase:
Phase II
Agency Tracking Number:
A2-4623
Solicitation Topic Code:
A09A-T004
Small Business Information
Enantigen Therapeutics, Inc
Pennsylvania Biotechnology Center, 3805 Old Easton Road, Doylestown, PA, 18902-8400
Hubzone Owned:
N
Woman Owned:
N
Socially and Economically Disadvantaged:
N
Duns:
828761697
Principal Investigator
 Xiaodong PhD
 President
 (215) 589-6350
 michaelxu@enantigen.com
Business Contact
 Kathleen MBA
Title: Grants Administrator
Phone: (215) 489-4944
Email: kczupich@artemis-finance.com
Research Institution
 New York University
 Richard Louth
 Department of Chemistry
100 Washington Square East
New York, NY, 18902-0000
 (212) 998-2121
 Nonprofit college or university
Abstract
This project builds on patterns derived from natural antimicrobial peptide sequences to develop novel compounds with better systemic activity, lower cytotoxicity and broader spectrum activity against multidrug resistant (MDR) pathogens. In Phase I and the

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government